Assuta Medical Center

Cancer Immunotherapy Market Set to Reach USD 296 Billion by 2033, Growing at 8.9% CAGR

a year ago

• The global cancer immunotherapy market is projected to grow from USD 126.19 billion in 2023 to USD 296.01 billion by 2033, with North America maintaining its dominant position at 45% market share. • Monoclonal antibodies currently dominate the market with 67% revenue share, while oncolytic viral therapies and cancer vaccines are expected to show significant growth in coming years. • Recent regulatory approvals, including FDA's authorization of ANKTIVA for bladder cancer and Amtagvi for melanoma, highlight the sector's innovation and expansion potential.